0.96 USD
↘ 0.01 (1.24%)AT CLOSE (11:59 AM EDT)
MIRA Pharmaceuticals, Inc. Common Stock
MIRANASDAQ • USD
0.94
↘ 0.02 (2.08%)
POST MARKET (AS OF 07:01 PM EDT)
Post Market
AS OF 07:01 PM EDT
0.94
↘ 0.02 (2.08%)
Market: CLOSED
Open?$0.96
High?$0.96
Low?$0.92
Prev. Close?$0.98
Volume?165.5K
Avg. Volume?132.2K
VWAP?$0.94
Rel. Volume?1.25x
Bid / Ask
Bid?$0.81 × 100
Ask?$1.10 × 100
Spread?$0.29
Midpoint?$0.95
Valuation & Ratios
Market Cap?40.3M
Shares Out?42.0M
Float?29.2M
Float %?69.5%
P/E Ratio?N/A
P/B Ratio?3.88
EPS?-$0.76
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Mira Pharmaceuticals Inc is a clinical-stage pharmaceutical development company focused on developing novel oral small-molecule therapeutics for neurologic, neuropsychiatric, metabolic, and inflammatory disorders. The company's pipeline includes three product candidates: Ketamir-2, MIRA-55, and SKNY-1, three drug candidates designed to address unmet medical needs across neuropathic and inflammatory pain, central nervous system disorders, and metabolic and behavioral conditions. The company operates as a single operating and reportable segment.
Employees
2
Market Cap
40.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2023-08-03
Address
1200 BRICKELL AVENUE
MIAMI, FL 33131
Phone: 813-369-5150
MIAMI, FL 33131
Phone: 813-369-5150
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?15.75Strong
Quick Ratio?15.75Strong
Cash Ratio?9.04Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUED
Score83/100
P/E?N/A▾
P/B?3.88FAIR▾
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-3.2CHEAP▾
EV/Sales?N/A▾
Returns & Efficiency
ROE?-307.9%WEAK▾
ROA?-288.5%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$34.0M
Fundamentals ratios updated end of day